Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with ...

Treatment with Kisunla was associated with sustained clinical benefits, specifically less symptom worsening and significant ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable setback" for those who hoped GLP-1 receptor agonists might slow Alzheimer's ...

A new multicenter study led by Mayo Clinic researchers has established a practical, evidence-based definition of rapidly progressive dementia (RPD), a rare but devastating form of cognitive decline ...

- Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI 12), 52% on activities of daily living, 91% on cognitive fluctuations, and 62% on motor symptoms as compared to placebo ...

Keep reading to learn how home gamma stimulation improved cognition and daily function in early Alzheimer disease.

After adjusting for age, hallucinations and a normal CSF white blood cell count were independently associated with rapidly progressive dementia. Factors such as hallucinations, cortical visual loss, ...